Skip to content

Evidence-based Patient Information and Decision Aids for Skin Cancer Patients

Evidence-based Patient Information and Decision Aids for Skin Cancer Patients - EPIDASC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00011411
Enrollment
1000
Registered
2016-12-08
Start date
2016-06-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C43

Interventions

Group 1: Melanoma patients (all stages) are investigated on their information needs, the use of information sources and offers and their satisfaction with information by means of a semi-standardized q

Sponsors

Universitätsklinikum Carl Gustav CarusHauttumorzentrum am Universitätskrebszentrum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Melanoma diagnosis, German language (spoken and understand), written consent

Exclusion criteria

Exclusion criteria: Physical, mental or linguistic impairments, which hinder the patient to give oral and written informed consent to study participation

Design outcomes

Primary

MeasureTime frame
Information needs of melanoma patients are investigated once using a semi-standardized questionnaire

Secondary

MeasureTime frame
Information sources, satisfaction with information, important qualities of doctor-patient communication and information sources Information behavior/usage, satisfaction with information status and sources, important qualities of doctor-patient communication and information sources (patient's view) are investigated once using the same semi-standardized questionnaire

Countries

Germany

Contacts

Public ContactJulia Brütting

Universitätsklinikum Carl Gustav Carus Dresden,Hauttumorzentrum am Universitätskrebszentrum,

julia.bruetting@uniklinikum-dresden.de0351 458 19617

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026